Review article: the patient with gastro‐oesophageal reflux disease – lifestyle advice and medication
- 1 December 2004
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 20 (s8) , 24-27
- https://doi.org/10.1111/j.1365-2036.2004.02224.x
Abstract
Article first published online: 1 DEC 2004Gastro-oesophageal reflux disease (GERD) is a highly prevalent disorder in all Western countries. Interestingly, prevalence rates appear to be increasing in these countries, with a remarkable increase of GERD-related lethal and nonlethal complications. However, these complications are rare on a global scale. This review aims to summarize the current concepts of genetic, lifestyle and environmental factors that need to be considered whilst caring for patients with these disorders. GERD is defined by the augmented exposure of oesophageal mucosa to acidic content, and is associated with specific symptoms or mucosal lesions. A number of factors may contribute to the manifestation of GERD. Although recent studies emphasize the role of genetic factors, there are many other risk factors that play a pivotal role in the development of GERD and GERD complications. Some nutritional factors are believed to aggravate acidic reflux either by delaying gastric emptying or diminishing the pressure of the lower oesophageal sphincters. Patients are often advised to sleep with their heads elevated, but this advice is not easy to follow and has not been proven effective with regard to long-term outcome. Other lifestyle modifications include changes to the patient's diet, which are important but not frequently sufficient. Thus, medication is usually necessary for symptom control. Proton pump inhibitors are now mainstream treatment for the reduction of acid secretion in patients with severe manifestations and 4-week healing rates are approaching 90%.G. Holtmann, B. Adam and T. LiebregtKeywords
This publication has 29 references indexed in Scilit:
- Changing patterns of peptic ulcer, gastro-oesophageal reflux disease and Helicobacter pyloriEuropean Journal of Gastroenterology & Hepatology, 2003
- GERD 2003 – A Consensus on the Way AheadDigestion, 2003
- Colonization with cagA-Positive Helicobacter pylori Strains Inversely Associated with Reflux Esophagitis and Barrett’s EsophagusDigestion, 2000
- BARRETT'S ESOPHAGUS: Reducing the Risk of Progression to AdenocarcinomaGastroenterology Clinics of North America, 1999
- Overweight, but Not High Dietary Fat Intake, Increases Risk of Gastroesophageal Reflux Disease HospitalizationAnnals of Epidemiology, 1999
- Epidemiology of abdominal symptoms in a random population: Prevalence, incidence, and natural historyEuropean Journal of Epidemiology, 1994
- Oesophageal and Gastric Potential Difference and pH in Healthy Volunteers Following Intake of Coca‐Cola, Red Wine, and AlcoholBasic & Clinical Pharmacology & Toxicology, 1993
- Epidemiology of gastro‐esophageal reflux diseaseWorld Journal of Surgery, 1992
- Epidemiology of Reflux Disease and Reflux EsophagitisScandinavian Journal of Gastroenterology, 1989
- Evaluation of elevation of the head of the bed, bethanechol, and antacid foam tablets on gastroesophageal refluxDigestive Diseases and Sciences, 1981